Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSPA: Satisfaction with Actonel in Osteoporosis
NCT00544180Phase 4Terminated
- Sponsor
- Sanofi
- Start
- May 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of risedronate in osteoporosis, sponsored by Sanofi. Primary endpoint: Patient satisfaction and compliance. Started May 2005; status: terminated.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00544180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544180.